• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过将氟康唑载入真菌壳聚糖纳米粒子来增强对耐药性念珠菌属的控制。

Augmented control of drug-resistant Candida spp. via fluconazole loading into fungal chitosan nanoparticles.

机构信息

Biochemistry Department, Faculty of Science, University of Tabuk, Saudi Arabia; Bioinformatics Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Sadat City, Egypt.

Biochemistry Department, Faculty of Science, University of Tabuk, Saudi Arabia.

出版信息

Int J Biol Macromol. 2019 Dec 1;141:511-516. doi: 10.1016/j.ijbiomac.2019.09.036. Epub 2019 Sep 6.

DOI:10.1016/j.ijbiomac.2019.09.036
PMID:31499111
Abstract

Fungal chitosan (ACT) extraction from Amylomyces rouxii, its transforming into nano-form, loading with fluconazole (Flu) and evaluation of synthesized nanoconjugates against drug-resistant (DR) Candida spp., were investigated. The produced ACT was characterized with 112.4 kDa molecular weight and 88.7% deacetylation degree. Synthesis of chitosan nanoparticles (NACT), and loading them with Flu were succeeded, using ionic gelation protocol, to generate stable Flu/NACT nanoconjugate' particles with mean size of 82 nm and zeta potential of +3.36 mV. The NACT entrapment efficiency was 78.7% and the drug loading capacity was 60.2%. Flu slowly released from NACT during the first 5 h, then release dramatically increased to the maximum (94.8%) after 12 h. The infra-red spectrum of Flu/NACT nanoconjugates confirmed the strong cross-linkage between their molecules. The antimycotic activity of NACT and Flu/NACT was proved against DR strains of C. albicans (2 strains), C. parapsilosis and C. glabrata, using qualitative and quantitative assays; Flu/NACT exhibited significant powerful activity, which was confirmed via observations with scanning microscopy. Finished cotton textiles with Flu/NACT had augmented potentiality for inhibiting challenged DR Candida spp., using in vitro assay. Accordingly, the synthesis and application of Flu/NACT nanoconjugates was astoundingly recommended for controlling DR Candida spp.

摘要

从粗糙脉孢菌中提取真菌壳聚糖(ACT),将其转化为纳米形式,负载氟康唑(Flu),并评价合成的纳米复合物对耐药(DR)念珠菌属的作用,进行了研究。所生产的 ACT 的分子量为 112.4 kDa,脱乙酰度为 88.7%。成功地使用离子凝胶化方案合成了壳聚糖纳米颗粒(NACT),并将其负载 Flu,以生成具有平均粒径为 82 nm 和 zeta 电位为+3.36 mV 的稳定 Flu/NACT 纳米复合物颗粒。NACT 的包封效率为 78.7%,载药量为 60.2%。Flu 在最初的 5 小时内从 NACT 缓慢释放,然后在 12 小时后急剧增加到最大值(94.8%)。Flu/NACT 纳米复合物的红外光谱证实了它们分子之间的强交联。通过定性和定量测定,证明了 NACT 和 Flu/NACT 对耐药性 C. albicans(2 株)、C. parapsilosis 和 C. glabrata 菌株的抗真菌活性;Flu/NACT 表现出显著的强大活性,通过扫描显微镜观察得到证实。使用体外试验,完成的带有 Flu/NACT 的棉纺织品对挑战耐药性念珠菌属的抑制具有增强的潜力。因此,强烈推荐合成和应用 Flu/NACT 纳米复合物来控制耐药性念珠菌属。

相似文献

1
Augmented control of drug-resistant Candida spp. via fluconazole loading into fungal chitosan nanoparticles.通过将氟康唑载入真菌壳聚糖纳米粒子来增强对耐药性念珠菌属的控制。
Int J Biol Macromol. 2019 Dec 1;141:511-516. doi: 10.1016/j.ijbiomac.2019.09.036. Epub 2019 Sep 6.
2
Enhanced antimycotic activity of nanoconjugates from fungal chitosan and Saussurea costus extract against resistant pathogenic Candida strains.真菌壳聚糖和雪莲提取物纳米缀合物对耐药性致病性念珠菌菌株的增强抗真菌活性。
Int J Biol Macromol. 2019 Dec 1;141:499-503. doi: 10.1016/j.ijbiomac.2019.09.022. Epub 2019 Sep 5.
3
Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.脂核纳米颗粒作为逆转多种念珠菌物种中氟康唑耐药性的广泛策略。
Colloids Surf B Biointerfaces. 2019 Mar 1;175:523-529. doi: 10.1016/j.colsurfb.2018.12.011. Epub 2018 Dec 6.
4
Time to overcome fluconazole resistant Candida isolates: Solid lipid nanoparticles as a novel antifungal drug delivery system.克服氟康唑耐药性念珠菌分离株的时间:固体脂质纳米粒作为一种新型抗真菌药物传递系统。
Colloids Surf B Biointerfaces. 2016 Jun 1;142:400-407. doi: 10.1016/j.colsurfb.2016.03.013. Epub 2016 Mar 5.
5
Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?来自癌症和非癌症混合患者群体的262株血流酵母菌分离株的抗真菌药敏性:体外对氟康唑的耐药性与真菌血症的结局之间是否存在相关性?
J Infect Chemother. 2000 Dec;6(4):216-21. doi: 10.1007/s101560070006.
6
Comparative Study of the Effects of Fluconazole and Voriconazole on Candida glabrata, Candida parapsilosis and Candida rugosa Biofilms.氟康唑和伏立康唑对光滑念珠菌、近平滑念珠菌和罗伊氏乳杆菌生物膜影响的比较研究。
Mycopathologia. 2018 Jun;183(3):499-511. doi: 10.1007/s11046-018-0243-z. Epub 2018 Jan 29.
7
Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV patients with candidiasis.多种蜂蜜对从患有念珠菌病的艾滋病患者中分离出的耐氟康唑念珠菌的杀菌效果。
J Mycol Med. 2017 Jun;27(2):159-165. doi: 10.1016/j.mycmed.2017.01.004. Epub 2017 Jan 31.
8
In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.卡泊芬净联合氟康唑对混合白念珠菌和光滑念珠菌生物膜的体外活性。
Med Mycol. 2016 May;54(4):384-93. doi: 10.1093/mmy/myv108. Epub 2016 Jan 14.
9
Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.泊沙康唑在阴道模型中对不同氟康唑敏感性的白色念珠菌分离株的治疗效果。
Med Mycol. 2007 May;45(3):221-4. doi: 10.1080/13693780601164298.
10
Antifungal activity of miconazole against recent Candida strains.咪康唑对近期念珠菌菌株的抗真菌活性。
Mycoses. 2010 Sep;53(5):434-7. doi: 10.1111/j.1439-0507.2009.01728.x. Epub 2009 Jun 15.

引用本文的文献

1
Fabrication of a sponge-like protein based hydrogel incorporating fluconazole against Candida species as a potential treatment for vulvovaginal candidiasis infection.制备一种含氟康唑的海绵状蛋白质基水凝胶,用于对抗念珠菌属,作为外阴阴道念珠菌病感染的潜在治疗方法。
Sci Rep. 2025 Jul 8;15(1):24364. doi: 10.1038/s41598-025-09457-2.
2
Microbial diversity and fitness in the gut-brain axis: influences on developmental risk for Alzheimer's disease.肠道-脑轴中的微生物多样性与适应性:对阿尔茨海默病发育风险的影响
Gut Microbes. 2025 Dec;17(1):2486518. doi: 10.1080/19490976.2025.2486518. Epub 2025 Apr 10.
3
The role of statistical methods in optimizing and enhancing fungal chitosan commercial production.
统计方法在优化和提高真菌壳聚糖商业生产中的作用。
3 Biotech. 2025 Mar;15(3):70. doi: 10.1007/s13205-025-04236-2. Epub 2025 Mar 1.
4
New advances in biological preservation technology for aquatic products.水产品生物保鲜技术的新进展。
NPJ Sci Food. 2025 Feb 3;9(1):15. doi: 10.1038/s41538-025-00372-4.
5
Reverse engineering the Gut-Brain Axis and microbiome-metabolomics for symbiotic/pathogenic balance in neurodegenerative diseases.对肠道-大脑轴和微生物组-代谢组学进行逆向工程,以实现神经退行性疾病中共生/致病平衡。
Gut Microbes. 2024 Jan-Dec;16(1):2422468. doi: 10.1080/19490976.2024.2422468. Epub 2024 Nov 10.
6
Bee chitosan nanoparticles loaded with apitoxin as a novel approach to eradication of common human bacterial, fungal pathogens and treating cancer.负载蜂毒素的蜂壳聚糖纳米颗粒作为根除常见人类细菌、真菌病原体及治疗癌症的新方法。
Front Microbiol. 2024 Mar 15;15:1345478. doi: 10.3389/fmicb.2024.1345478. eCollection 2024.
7
Superficial Dermatophytosis across the World's Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges.全球人群中的浅表皮肤癣菌病:基于纳米载体疗法的潜在益处及日益增加的挑战
ACS Omega. 2023 Aug 22;8(35):31575-31599. doi: 10.1021/acsomega.3c01988. eCollection 2023 Sep 5.
8
Synthesis and characterization of Hyaluronic Acid (HA) modified polymeric composite for effective treatment of wound healing by transdermal drug delivery system (TDDS).透明质酸(HA)修饰的聚合物复合材料的合成与表征及其在经皮给药系统(TDDS)中有效治疗伤口愈合的应用。
Sci Rep. 2023 Aug 17;13(1):13425. doi: 10.1038/s41598-023-40593-9.
9
Emerging Polymer-Based Nanosystem Strategies in the Delivery of Antifungal Drugs.基于聚合物的新型纳米系统在抗真菌药物递送中的策略
Pharmaceutics. 2023 Jul 1;15(7):1866. doi: 10.3390/pharmaceutics15071866.
10
Chitosan-Albumin Nanocomposite as a Promising Nanocarrier for Efficient Delivery of Fluconazole Against Vaginal Candidiasis.壳聚糖-白蛋白纳米复合材料作为一种有前景的纳米载体用于高效递送氟康唑治疗阴道念珠菌病
Appl Biochem Biotechnol. 2024 Feb;196(2):701-716. doi: 10.1007/s12010-023-04492-z. Epub 2023 May 13.